Hopp til hovedinnhold

Polyfarmasi hos eldre

Sist revidert:
Sist revidert av:
  1. Rochon PA. Drug prescribing for older adults. UpToDate, last updated Nov 07, 2022. UpToDate  
  2. Pretorius RW, Gataric G, Swedlund SK, Miller JR. Reducing the risk of adverse drug events in older adults. Am Fam Physician. 2013;87(5):331-336. PubMed  
  3. Cho S, Lau SW, Tandon V, et al. Geriatric drug evaluation: where are we now and where should we be in the future? Arch Intern Med 2011; 171:937. PubMed  
  4. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370:173. PubMed  
  5. Rørvik FB, Laake K. Medisinering hos pensjonærer i alders- og sykehjem. Tidsskr Nor Lægeforen 1990; 110: 1335-8. PubMed  
  6. Gulla C. A Fine Balance: Drug Use in Norwegian Nursing Homes. Doktorgradsavhandling, 2018. www.uib.no  
  7. Halvorsen KH, Ruths S, Granas AG, Viktil KK. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scandinavian Journal of Primary Health Care. 2010;28(2):82-8. PubMed  
  8. Kragh A. Två av tre på äldreboenden behandlas med minst tio läkemedel. Kartläggning av läkemedelsförskrivningen i nordöstra Skåne. Läkartidningen 2004; 101: 994-9.
  9. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011;86:304-14. PubMed  
  10. Rosenson RS, Reeder GS, Kennedy HL. Acute myocardial infarction: Role of beta blocker therapy. UpToDate, last updated Dec 02, 2020. UpToDate  
  11. Spigset O. Bruk av legemidler hos eldre. Utposten, nr. 4, 2003.
  12. Ruths S, Straand J. Eldre og legemidler. Oslo: Norsk legemiddelhåndbok, 31.12.2015. legemiddelhandboka.no  
  13. Alldred DP, Raynor DK, Hughes C, et al. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev 2013; 2:CD009095. Cochrane (DOI)  
  14. Fried TR, O'Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc 2014; 62:2261. PubMed  
  15. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157: 1531-6. PubMed  
  16. Musini VM, Tejani AM, Bassett K, et al. Pharmacotherapy for hypertension in adults 60 years or older. Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD000028. DOI: 10.1002/14651858.CD000028.pub3. DOI  
  17. Vaduganathan M, Claggett BL, Jhund PS, et al. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Lancet. 2020;396(10244):121-128. PubMed  
  18. Metra M, Teerlink JR. Heart failure. Lancet. 2017;390(10106):1981-1995. PubMed  
  19. Vinci P, Panizon E, Tosoni LM, et al. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy. Int J Mol Sci. 2021;22(21):11687. Published 2021 Oct 28.
  20. Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD001927. DOI: 10.1002/14651858.CD001927.pub2. DOI  
  21. Aguilar MI, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD001925. DOI: 10.1002/14651858.CD001925.pub2. DOI  
  22. Helvik, AS., Šaltytė Benth, J., Wu, B. et al. Persistent use of psychotropic drugs in nursing home residents in Norway. BMC Geriatr 17, 52 (2017). PMID: 28193181 PubMed  
  • Olav Spigset overlege, professor, dr.med., Avdeling for legemidler, St. Olavs Hospital